Austar Lifesciences Limited (HKG:6118)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.720
+0.010 (1.41%)
Mar 10, 2026, 4:08 PM HKT
-12.20%
Market Cap 363.93M
Revenue (ttm) 1.60B
Net Income (ttm) 38.57M
Shares Out 512.58M
EPS (ttm) 0.08
PE Ratio 9.44
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 245,000
Average Volume 170,950
Open 0.710
Previous Close 0.710
Day's Range 0.700 - 0.780
52-Week Range 0.650 - 1.970
Beta 1.21
RSI 40.28
Earnings Date Mar 27, 2026

About Austar Lifesciences

Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. It also offers clean utility and bioprocess equipment, clean room, automation control and monitor system; bioprocess equipment consumab... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1991
Employees 1,446
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6118
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.